trial · primary record
Ramantamig
Multiple Myeloma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1000 |
| Primary completion | 2037-01-11 |
| Primary endpoint | Progression-Free Survival (PFS) |
| Registry ID | NCT07903272 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:38.088Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07903272
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.